Wolters Kluwer Health has announced that KLAS Research has recognized Sentri7® clinical surveillance solutions as Best in KLAS® for both Pharmacy Surveillance and Infection Control and Monitoring in the ‘2026 Best in KLAS – Software and Services’ report released recently. KLAS Research, which monitors and reports on the performance of healthcare solution providers, rated the evidence-based Sentri7 solutions as market leaders for hospitals focused on optimizing infection prevention (IP) programs and hospital pharmacy performance.
The Wolters Kluwer Sentri7 suite is positioned as a single-platform solution designed to support comprehensive clinical surveillance and medication management. Through real-time patient identification, clinicians are able to prioritize at-risk patients and intervene earlier, supporting time savings and workflow efficiency. Sentri7 Pharmacy Surveillance is described as supporting pharmacy leaders in improving hospital performance by lowering medication use and costs while also decreasing risk and mortality. Hospital pharmacies use the solution to support patient care, safety, and satisfaction, and it has been identified as influencing patient outcomes and operational efficiency.
Sentri7 Infection Prevention is described as supporting infection prevention programs by accelerating the identification of healthcare-acquired infections (HAIs) and emerging trends. The solution’s capabilities are intended to support care teams in enhancing quality, reducing costs, and improving patient outcomes, while also simplifying regulatory reporting so healthcare professionals can focus on patient care delivery.
The recognition reflects customer trust and feedback, with infection control, monitoring, and pharmacy surveillance identified as critical areas for driving operational and regulatory efficiencies in hospitals. The announcement references the use of advanced technology, real-time visibility, and automated reporting to support hospital leaders in optimizing processes, reducing costs, and improving patient outcomes.
KLAS Research conducts interviews with thousands of healthcare professionals and uses their responses to evaluate innovative software across areas that include Culture, Loyalty, Operations, Product Features, Relationship, and Value. Survey responses cited benefits associated with Sentri7 solutions such as real-time insights, time savings, and improved workflows, including feedback describing live data access, customizable rules for clinical monitoring, and reporting efficiencies that significantly reduced time required for daily tasks.
Best in KLAS is described as an award program that recognizes health technology solution providers for efforts supporting healthcare professionals in delivering patient care. The designation applies to software and services market segments with broad operational and clinical impact on healthcare organizations, and the recognition reflects customer trust earned over the past year.
Click here to read the original press release.
